Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shareholders of $ENZC$ should look at what is about to take place as the equivalent of a forward stock split. The outlook for continual growth and profitability is very BULLISH.
"Regarding the definitive purchase agreement, it is being finalized with an expected execution date of May 19, 2023. The previous release stated the transaction was expected to close on May 19, 2023, which was an error. Once the transaction document is finalized it will be subject to regulatory approval."
" buy the dips all the way to Nasdaq ". Where HOLY at.
Patience people. Patience.
Let's see how this unfolds in another month.
Miller Wealth Advisors, Llc's new positions include Tesla Motors, Inc. (US:TSLA) , ProShares UltraShort DJ-UBS Natural Gas ETF (US:KOLD) , Direxion Daily FTSE China Bear 3X Shares (US:YANG) , Remote Dynamics Inc (US:RMTD)
Why would a Wealth Advisory service with 80 years of experience be holding a defunct company like RMTD in their portfolio????? Just curious.
I understand your frustration, however things happen Beyond their control at times. That's why they've gone tight lipped. Their grinding and in due time the work will prove true. Be patient
People just need to realize
“It will take longer than you expect — don’t give up.” Charles Cotropia of BioClonetics Immunotherapeutics.
This is just the tip of the iceberg. Be patient. Patents, Clone 3 etc....
Be patient.
Name me one not two but one company in our teir, on the OTC that actually has products that you can actually purchase that helps individuals prolong life. Now about to attack a plague that has taken millions of lives. This shit takes time man. Least we can do is be patient.
From
Note 12. Subsequent Events
On April 11, 2023 Virogentics a wholly owned subsidiary of the company completed the production of the Vials needed
for the African project and is ready for use in selected hospitals in Africa.
"Development of a new therapy in the pharma industry faces many unexpected barriers. You would expect that a demonstrated technology that could successfully help 36 million people infected with HIV and that could possibly change the fate of over 1 million who die each year from the virus, would garner support from those in the industry. We have found this is not the case. If a therapy is “not invented here” and there is less than animal or clinical trial evidence (which costs millions of dollars) that removes all possible doubt about its success, very few will be interested. So, the difficulty is not only creating unbelievable technology, but once created, finding a meaningful partner or the huge sums of money needed to independently carry the technology to market."
Be patient people. Be patient.
“Patience is bitter, but its fruit is sweet.” Aristotle.
$$$$ENZC$$$$
Lol. I must say you have a point. Atleast now we start revenue stream. $ENZC$
Thank goodness we a CEO that's a patent Lawyer. This article explains how Big Pharma has a stranglehold on the industry through patent issuance.
https://www.ft.com/content/c5498e67-a48f-4adc-b85f-7bf1a0d400f6
I'm just glad your BULLISH for $ENZC$. Glad to have you here.
Sir, wether it's DC or Marvel characters. Enzc is what we're fighting for. Not against. LET'S GO ENZC.
Lol. Good one.
Much respect to MAGA and any pro ENZCers. Even the naysayers, they provide balance. Much respect to the people who provide valuable intel to this forum so people can make some money to support themselves and loved ones. This stock has been a blessing to many. It's not easy out there. So when people volunteer Intel that provides insight to the less informed. That should be commended. Life is all about adjustments. This is a swing trading pattern right now. Why complain. Open another brokerage account and start trading away. This will take some time to establish. JMO
$$$$$$$$$$RMTD$$$$$$$$$$
This defunct egnamic of of a stock. Years ago I came In contact with a lady that was apart of the Telogis and another Telematics Company merge deal. She was shocked that I knew about Telogis. I told her that I was invested in an OTC company called Remote Dynamics and that's when her eyes opened wider. Of course she wouldn't or couldn't tell me much but the look in her eyes said it all. No need for me to lie. Trackkkk, her name is Jill Ward. Nice lady. Shrewd business woman. Trackkkk, I know your investigate skills are top notch when it comes to these things. Just a shot in the dark. Then I had a vision of this ticker pumping to insane levels. Clear as day. For no apparent reason. I've sold and bought back numerous runs. Here I am again. This time the lights are off but something tells me behind the scenes something is quietly brewing. It's sleeping now but this is the OTC and very unpredictable. Just thought I'd get that off my chest.
https://www.biopharmadive.com/news/pharma-patent-cliff-biologic-drugs-humira-keytruda/642660/
Once $ENZC$ has established proof of concept of their drugs and their patents are approved. BOOOOOOOM! Big pharma will have no choice but to do business with $ENZC$
What's one man's trash shall be another man's treasure.
$ENZC$
True True
Lol. This is a 2023 to 2024 stock. Their in the lab cooking it up.
Between now and end of March 2023 NEWS of progress will give investors here a sigh of relief. Be patient.
It's coming, it's in production. In the meantime keep watching the reruns.
Haven't we've seen this movie already???
PUMP AND DUMP!!!
Without SUBSTANTIAL NEWS it's a swing traders paradise.
Nothing wrong with that. Make money but let's not get it confused.
$$$$$$$$ENZC$$$$$$$$$$$$$$$$$$$$$$
$RMTD$$$$$$$$$$$$$$$$$$$$$$
$$$$ENZC$$$$
$ENZC$
$RMTD$
$RMTD$
$ENZC$
To accelerate and fully execute in the successful production of the multiple monoclonal antibodies the subject of the Company's intellectual property (specifically the numerous monoclonal antibodies (mAbs) targeting both human and animal viruses), the Company continuously engages with numerous entities to accomplish the successful goal of production, testing and delivery of successful therapeutics. Entities with whom the Company is working includes companies having:
Expertise in providing specialized peptides having precise amino acid sequences corresponding to the precise target sites on both the Coronavirus and HIV viruses which are then used in the Company's Texas lab against which mAbs are being produced. This strategy accelerates the production of the mAbs for further development.
Specialized cell soring technology that is complementary to the process used in the Company's lab to accelerate production of mAbs for advancing production.
Expertise in hybridoma production techniques for production of mAbs using hybridoma methodologies that are complementary to the process used in the Company's lab.
Animal trials centers, both in the U.S. and abroad, for preparation of animal trials.
Promotional entities with specialized expertise in targeting large funding sources for the purpose of raising the substantial funds needed for the production of the recombinant mAbs necessary for future trials and for conducting animal trials.
The Daily Hodl: Ethereum Whales Pile Into Dogecoin Competitor Shiba Inu As Holdings Explode by Over 500%.
https://dailyhodl.com/2022/07/29/ethereum-whales-pile-into-dogecoin-competitor-shiba-inu-as-holdings-explode-by-over-500/
$$$$RMTD$$$$
$$$$ENZC$$$$
$$$$RMTD$$$$
$$$$ENZC$$$$
I agree 1000%.
$ENZC$